뒤로
Biocure Technology Inc (BICTF) 주가 예측
BICTF 주가 차트
BICTF 주가 예측
Biocure Technology Inc
$0.01
0%
$0
종가: Mar 24, 16:00:00 GMT-4
$0.01
0%
$0
애프터마켓: Mar 24, 17:50:13 GMT-4
주요 통계
이전 종가
$0.01
시가
$0.01
일일 범위
$0.01 - $0.07
52주 범위
$0.0012 - $0.63
거래량
1.0K
평균 거래량
0
배당수익률
--
EPS(TTM)
-0.02
시가총액
$154.4K
BIOCURE TECHNOLOGY INC란 무엇인가요?
Biocure Technology, Inc. engages in the development and commercialization of biosimilar products. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2008-03-27. The firm specializes in the development and commercialization of its own CAR T-cell therapy, targeting Chronic lymphocytic leukemia and solid tumor cancers. Additionally, the Company is developing biosimilar technologies for cancer treatment. The Company’s products include Interferon Beta, Ranibizumab and PEG-Filgrastim.